Maven Securities LTD Mersana Therapeutics, Inc. Transaction History

Maven Securities LTD

  • $1.61 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$8.56 - $14.47 $723,054 - $1.22 Million
-84,469 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$13.28 - $18.07 $1.12 Million - $1.53 Million
84,469 New
84,469 $1.17 Million
Q4 2020

Feb 12, 2021
SELL
$16.84 - $27.59 $1.18 Million - $1.93 Million
-70,100 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$16.2 - $25.7 $1.14 Million - $1.8 Million
70,100 New
70,100 $1.31 Million

Others Institutions Holding MRSN

# of Institutions
128
Shares Held
118M
Call Options Held
68.1K
Put Options Held
140K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $178M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email